Factors affecting the ability of energy functions to discriminate correct from incorrect folds.

PubWeight™: 1.84‹?› | Rank: Top 3%

🔗 View Article (PMID 9102472)

Published in J Mol Biol on March 07, 1997

Authors

B H Park1, E S Huang, M Levitt

Author Affiliations

1: Beckman Laboratories for Structural Biology, Department of Structural Biology, Stanford University of Medicine, CA 94305-5400, USA.

Articles citing this

Statistical potential for assessment and prediction of protein structures. Protein Sci (2006) 8.98

Can correct protein models be identified? Protein Sci (2003) 3.74

Statistical potentials for fold assessment. Protein Sci (2002) 2.92

Identification of correct regions in protein models using structural, alignment, and consensus information. Protein Sci (2006) 2.39

Decoys 'R' Us: a database of incorrect conformations to improve protein structure prediction. Protein Sci (2000) 2.10

A composite score for predicting errors in protein structure models. Protein Sci (2006) 1.92

Prediction of Protein Loop Conformations using the AGBNP Implicit Solvent Model and Torsion Angle Sampling. J Chem Theory Comput (2008) 1.72

The FEATURE framework for protein function annotation: modeling new functions, improving performance, and extending to novel applications. BMC Genomics (2008) 1.64

Contact order and ab initio protein structure prediction. Protein Sci (2002) 1.59

How well can the accuracy of comparative protein structure models be predicted? Protein Sci (2008) 1.52

Orientational potentials extracted from protein structures improve native fold recognition. Protein Sci (2004) 1.40

Fold assessment for comparative protein structure modeling. Protein Sci (2007) 1.31

Inferring ideal amino acid interaction forms from statistical protein contact potentials. Proteins (2005) 1.24

Discriminative learning for protein conformation sampling. Proteins (2008) 1.15

Improved protein structure selection using decoy-dependent discriminatory functions. BMC Struct Biol (2004) 1.15

Towards the high-resolution protein structure prediction. Fast refinement of reduced models with all-atom force field. BMC Struct Biol (2007) 1.10

Local quality assessment in homology models using statistical potentials and support vector machines. Protein Sci (2007) 1.00

Hydrophobicity--shake flasks, protein folding and drug discovery. Curr Top Med Chem (2010) 1.00

Improved recognition of native-like protein structures using a family of designed sequences. Proc Natl Acad Sci U S A (2002) 0.97

Interatomic potentials and solvation parameters from protein engineering data for buried residues. Protein Sci (2002) 0.96

Toward predicting protein topology: an approach to identifying beta hairpins. Proc Natl Acad Sci U S A (2002) 0.96

Statistical potential for modeling and ranking of protein-ligand interactions. J Chem Inf Model (2011) 0.95

Nonbonded terms extrapolated from nonlocal knowledge-based energy functions improve error detection in near-native protein structure models. Protein Sci (2007) 0.95

What should the Z-score of native protein structures be? Protein Sci (1998) 0.88

Protein structure prediction by all-atom free-energy refinement. BMC Struct Biol (2007) 0.87

Using neural networks and evolutionary information in decoy discrimination for protein tertiary structure prediction. BMC Bioinformatics (2008) 0.83

Improving the accuracy of template-based predictions by mixing and matching between initial models. BMC Struct Biol (2008) 0.82

Assessment of Semiempirical Quantum Mechanical Methods for the Evaluation of Protein Structures. J Chem Theory Comput (2007) 0.82

Evolutionary potentials: structure specific knowledge-based potentials exploiting the evolutionary record of sequence homologs. Genome Biol (2008) 0.81

A physical approach to protein structure prediction. Biophys J (2002) 0.81

Distance geometry generates native-like folds for small helical proteins using the consensus distances of predicted protein structures. Protein Sci (1998) 0.80

A protein folding potential that places the native states of a large number of proteins near a local minimum. BMC Struct Biol (2002) 0.80

A novel method for predicting and using distance constraints of high accuracy for refining protein structure prediction. Proteins (2009) 0.79

An information theoretic approach to macromolecular modeling: II. Force fields. Biophys J (2005) 0.79

A contact energy function considering residue hydrophobic environment and its application in protein fold recognition. Genomics Proteomics Bioinformatics (2005) 0.77

3DRobot: automated generation of diverse and well-packed protein structure decoys. Bioinformatics (2015) 0.77

Toward correct protein folding potentials. J Biol Phys (2004) 0.75

Selective refinement and selection of near-native models in protein structure prediction. Proteins (2015) 0.75

Articles by these authors

The ASTRAL compendium for protein structure and sequence analysis. Nucleic Acids Res (2000) 11.38

Theoretical studies of enzymic reactions: dielectric, electrostatic and steric stabilization of the carbonium ion in the reaction of lysozyme. J Mol Biol (1976) 9.91

p53: a frequent target for genetic abnormalities in lung cancer. Science (1989) 7.51

A simplified representation of protein conformations for rapid simulation of protein folding. J Mol Biol (1976) 7.06

Structure of nucleosome core particles of chromatin. Nature (1977) 6.24

Structural patterns in globular proteins. Nature (1976) 5.95

Studies on the mechanism of action of nalidixic acid. Antimicrob Agents Chemother (1973) 5.64

Computer simulation of protein folding. Nature (1975) 5.34

Conformations of immunoglobulin hypervariable regions. Nature (1990) 5.31

Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94

Structural polypeptides of simian virus 40. J Virol (1971) 4.83

Protein normal-mode dynamics: trypsin inhibitor, crambin, ribonuclease and lysozyme. J Mol Biol (1985) 4.56

Human cytomegalovirus. I. Purification and characterization of viral DNA. J Virol (1973) 4.43

Helix to helix packing in proteins. J Mol Biol (1981) 4.24

Human cytomegalovirus. III. Virus-induced DNA polymerase. J Virol (1975) 4.06

Conformational preferences of amino acids in globular proteins. Biochemistry (1978) 4.00

Analysis of simian virus 40 DNA with the restriction enzyme of Haemophilus aegyptius, endonuclease Z. J Virol (1973) 3.98

Desire for death in the terminally ill. Am J Psychiatry (1995) 3.87

Energy functions that discriminate X-ray and near native folds from well-constructed decoys. J Mol Biol (1996) 3.86

Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 3.82

Detailed molecular model for transfer ribonucleic acid. Nature (1969) 3.81

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol (1984) 3.76

How many base-pairs per turn does DNA have in solution and in chromatin? Some theoretical calculations. Proc Natl Acad Sci U S A (1978) 3.55

Refinement of protein conformations using a macromolecular energy minimization procedure. J Mol Biol (1969) 3.21

Stimulation of cellular thymidine kinases by human cytomegalovirus. J Virol (1977) 3.17

The PRESAGE database for structural genomics. Nucleic Acids Res (1999) 3.03

Human cytomegalovirus. IV. Specific inhibition of virus-induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid. J Virol (1975) 2.64

Human cytomegalovirus genome: partial denaturation map and organization of genome sequences. J Virol (1977) 2.63

Comprehensive assessment of automatic structural alignment against a manual standard, the scop classification of proteins. Protein Sci (1998) 2.60

Structure of proteins: packing of alpha-helices and pleated sheets. Proc Natl Acad Sci U S A (1977) 2.60

Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A (1983) 2.54

Detection of human cytomegalovirus and analysis of strain variation. Yale J Biol Med (1976) 2.53

Structural similarity of DNA-binding domains of bacteriophage repressors and the globin core. Curr Biol (1993) 2.53

Protein folding by restrained energy minimization and molecular dynamics. J Mol Biol (1983) 2.51

Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35

Molecular dynamics of native protein. II. Analysis and nature of motion. J Mol Biol (1983) 2.29

Automatic identification of secondary structure in globular proteins. J Mol Biol (1977) 2.25

The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol (1997) 2.24

Energy refinement of hen egg-white lysozyme. J Mol Biol (1974) 2.24

A humanized antibody that binds to the interleukin 2 receptor. Proc Natl Acad Sci U S A (1989) 2.23

Stabilization of phage T4 lysozyme by engineered disulfide bonds. Proc Natl Acad Sci U S A (1989) 2.17

Structure and function of the polypeptides in simian virus 40. I. Existence of subviral deoxynucleoprotein complexes. J Virol (1972) 2.16

Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol (1995) 2.16

Decoys 'R' Us: a database of incorrect conformations to improve protein structure prediction. Protein Sci (2000) 2.10

Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro. Antimicrob Agents Chemother (1983) 2.09

Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J Virol (2001) 2.07

Ab initio construction of protein tertiary structures using a hierarchical approach. J Mol Biol (2000) 2.05

E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Mol Cell Biol (1992) 2.01

Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3). Mol Cell Biol (1993) 2.00

Human cytomegalovirus. II. Lack of relatedness to DNA of herpes simples I and II, Epstein-Barr virus, and nonhuman strains of cytomegalovirus. J Virol (1974) 1.99

Molecular dynamics simulation of photodissociation of carbon monoxide from hemoglobin. Proc Natl Acad Sci U S A (1985) 1.94

A brighter future for protein structure prediction. Nat Struct Biol (1999) 1.93

Molecular dynamics simulations of helix denaturation. J Mol Biol (1992) 1.92

The volume of atoms on the protein surface: calculated from simulation, using Voronoi polyhedra. J Mol Biol (1995) 1.92

Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer (1980) 1.90

Periodicity of deoxyribonuclease I digestion of chromatin. Science (1979) 1.90

Molecular dynamics of native protein. I. Computer simulation of trajectories. J Mol Biol (1983) 1.87

Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1. J Virol (1976) 1.87

The complexity and accuracy of discrete state models of protein structure. J Mol Biol (1995) 1.86

Recognizing native folds by the arrangement of hydrophobic and polar residues. J Mol Biol (1995) 1.85

Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci U S A (1993) 1.84

Computer simulation of DNA double-helix dynamics. Cold Spring Harb Symp Quant Biol (1983) 1.81

Climate change and the integrity of science. Science (2010) 1.80

A lattice model for protein structure prediction at low resolution. Proc Natl Acad Sci U S A (1992) 1.80

Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J Immunol (1999) 1.79

Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters. J Virol (1997) 1.78

L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU). Cancer (1977) 1.74

Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins. J Virol (1993) 1.73

Cytotoxicity of sesquiterpene lactones. Cancer Res (1971) 1.71

The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure. Science (1986) 1.68

Protein unfolding pathways explored through molecular dynamics simulations. J Mol Biol (1993) 1.67

Expectations from structural genomics. Protein Sci (2000) 1.65

Accurate prediction of the stability and activity effects of site-directed mutagenesis on a protein core. Nature (1991) 1.65

Polymerase chain reaction to detect human cytomegalovirus in livers of infants with neonatal hepatitis. Gastroenterology (1992) 1.64

Exploring conformational space with a simple lattice model for protein structure. J Mol Biol (1994) 1.63

The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J Virol (1996) 1.63

Nucleotide sequence of a human cytomegalovirus DNA fragment encoding a 67-kilodalton phosphorylated viral protein. J Virol (1985) 1.62

Cytomegalovirus: genetic variation of viral genomes. Ann N Y Acad Sci (1980) 1.59

Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet (1982) 1.59

A model of the molten globule state from molecular dynamics simulations. Proc Natl Acad Sci U S A (1992) 1.56

Mapping and expression of a human cytomegalovirus major viral protein. J Virol (1984) 1.55

Quantification of the hydrophobic interaction by simulations of the aggregation of small hydrophobic solutes in water. Proc Natl Acad Sci U S A (2001) 1.55

A new class of tyrosine hydroxylase inhibitors and a simple assay of inhibition in vivo. Biochem Pharmacol (1967) 1.54

De novo protein design. II. Plasticity in sequence space. J Mol Biol (1999) 1.53

Long-term persistence of cytomegalovirus genome in cultured human cells of prostatic origin. J Virol (1975) 1.48

Autologous human B and T lymphoblastoid cell lines. Nature (1974) 1.48

Structure and function of the polypeptides in simian virus 40. II. Transcription of subviral deoxynucleoprotein complexes in vitro. J Virol (1972) 1.47

Realistic simulations of native-protein dynamics in solution and beyond. Annu Rev Biophys Biomol Struct (1993) 1.46

Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product. J Virol (1992) 1.46

Molecular epidemiology of cytomegalovirus infections in women and their infants. N Engl J Med (1980) 1.46

The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics. J Virol (1996) 1.44

A structural census of the current population of protein sequences. Proc Natl Acad Sci U S A (1997) 1.44

Discontinuation of antistreptococcal prophylaxis. A double-blind study in rheumatic patients free of heart disease. JAMA (1966) 1.42

Using iterative dynamic programming to obtain accurate pairwise and multiple alignments of protein structures. Proc Int Conf Intell Syst Mol Biol (1996) 1.41

Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine. J Virol (1985) 1.40

Making up inotrope solutions. Anaesthesia (1992) 1.39

Molecular dynamics of hydrogen bonds in bovine pancreatic trypsin inhibitor protein. Nature (1981) 1.38

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med (1987) 1.38

Practice parameters for the management of colonic cancer I: surgical issues. Recommendations of the Colorectal Surgical Society of Australia. Aust N Z J Surg (1999) 1.38